Cowen and Company’s Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CHEB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-162,208
Closed -$11.4K 375
2024
Q3
$11.4K Buy
+162,208
New +$13.5K ﹤0.01% 487

Other funds holding CHEB.WS

Cowen and Company's CHEB.WS Position: Q4 2024 in Review

Cowen and Company sold out of Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CHEB.WS) in Q4 2024, closing a stake of 162,208 shares — an estimated $11.4K sold.

Cowen and Company first reported a position in CHEB.WS in Q3 2024 and held it in 1 quarter. The position peaked at $11.4K in Q3 2024. 24 funds tracked by Wall St. Rank hold CHEB.WS as of Q4 2024.

  • Cowen and Company reported no remaining Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 162,208 Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2024, an estimated $11.4K.
  • Cowen and Company first reported a position in Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2024 and held it in 1 quarter.
  • Cowen and Company's Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $11.4K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.